Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa vs daily follitropin beta in oocyte donors under MPA suppression
2023-506908-66-00Phase 3Authorised
- Sponsor
- IVI Valencia
- Start
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of corifollitropin alfa in female infertility (2 arms), sponsored by IVI Valencia. Primary endpoints: Number of MII oocytes and Mature oocyte rate. Planned start Dec 2023; status: authorised.
02
Drugs
corifollitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on 2023-506908-66-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506908-66-00.